GRIFOLS reported €397.86M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Alcon AG ALC:SW 1.37B 198M
Amadeus IT AMS:SM € 1490.3M 418.3M
Amarin AMRN:US $ 327.02M 36.02M
AstraZeneca AZN:LN 15567M 7931M
Bayer BAYN:GR € 3389M 2161M
Ferrovial FER:SM € 5116M 886M
Fresenius FRE:GR € 2250M 373M
Fresenius Medical Care FME:GR € 1408M 335M
Genmab GEN:DC DK 9477M 1585M
GlaxoSmithKline GSK:LN 3503M 1254M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 2M 321M
Inditex ITX:SM € 7611M 527M
Merck MRK:GR € 1825M 413M
Novartis NOVN:VX SF 5117M 1316M
Philips PHIA:NA € 1003M 37M